Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183599 · ClinicalTrials.gov registry record · NA

Gambling and Brief Interventions

A NA study of Gambling, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
500
Enrollment target
6
Study locations

NCT00183599: Completed NA study of Gambling, sponsored by UConn Health.

NCT00183599 is a NA study of Gambling that has completed, run by UConn Health. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00183599, a NA study of Gambling, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
6
Study locations

Study Summary

This study will compare four different combinations and durations of motivational enhancement therapy, cognitive behavioral therapy, and brief advice treatments for gambling versus a non-intervention condition to determine which is most effective in reducing problem gambling.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL 5 Minutes of Simple Advice
  • BEHAVIORAL Motivational Enhancement Therapy (MET)

Study Locations (6)

Connecticut

  • LMG - Bridgeport
  • University of Connecticut Health Center - Farmington
  • CSAC - Hartford
  • Southern CT State University - New Haven
  • LMG - Stamford
  • University of Connecticut - Storrs

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 1999-04
Est. Completion 2007-03
Phase NA
UConn Health

178 total trials

What the finished NCT00183599 record still lists

NCT00183599 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Gambling appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00183599 lists 6 locations in 1 state (Connecticut).

Frequently Asked Questions

What is clinical trial NCT00183599 about?

NCT00183599 is a clinical study titled "Gambling and Brief Interventions". This study will compare four different combinations and durations of motivational enhancement therapy, cognitive behavioral therapy, and brief advice treatments for gambling versus a non-intervention condition to determine which is most effective in reducing problem gambling.

What is the current status of trial NCT00183599?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 1999-04. Estimated completion is 2007-03.

What conditions does trial NCT00183599 study?

This clinical trial studies the following conditions: Gambling.

What interventions are being tested in trial NCT00183599?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), 5 Minutes of Simple Advice (BEHAVIORAL), Motivational Enhancement Therapy (MET) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00183599?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00183599 being conducted?

This trial has 6 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gambling

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00183599's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00183599, the US trial registry maintained by the National Library of Medicine. NCT00183599 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.